Longitudinal study on health-related quality of life in a cohort of 96 patients with common variable immune deficiencies

Frontiers in Immunology

Volumn 5, Issue NOV, 2014, Pages

  Tabolli, Stefano ^a   Giannantoni, Patrizia ^a   Pulvirenti, Federica ^b   La Marra, Fabiola ^b   Granata, Guido ^b   Milito, Cinzia ^b   Quinti, Isabella ^a,b  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Common variable immune deficiencies; GHQ 12; Health related quality of life; Immunoglobulins; Sf 36

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; ANXIETY; ARTICLE; BODILY PAIN SCORE; CHRONIC DISEASE; COHORT ANALYSIS; COMMON VARIABLE IMMUNODEFICIENCY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEATH; DEPRESSION; FEMALE; GENERAL HEALTH QUESTIONNAIRE; GLOBAL ASSESSMENT OF FUNCTIONING; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; MENTAL COMPONENT SCORE; MENTAL HEALTH; MIDDLE AGED; MORTALITY; OBSERVATIONAL STUDY; PATIENT ASSESSMENT; PHYSICAL COMPONENT SUMMARY SCORE; PHYSICAL FUNCTIONING SCORE; QUALITY OF LIFE; RISK FACTOR; ROLE EMOTIONAL SCALE; ROLE PHYSICAL SCORE; SCORING SYSTEM; SHORT FORM 36; SOCIAL FUNCTIONING SCORE;

EID: 84919442193     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00605     Document Type: Article

References (25)

1. World Health Organization. The World Health Report 2011: Mental Health: New Understanding, New Hope. Geneva: WHO (2001).
2. Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood (2008) 112:277-86. doi:10.1182/blood-2007-11-124545
3. Warnatz K, Denz A, Drager R, Braun M, Groth C, Wolff-Vorbeck G, et al. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood (2002) 99:1544-51. doi:10.1182/blood.V99.5.1544
4. Espanol T, Prevot J, Drabwell J, Sondhi S, Olding L. Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment. Patient Prefer Adherence (2014) 8:621-9. doi:10.2147/PPA.S60771
5. Daly PB, Evans JH, Kobayashi RH, Kobayashi AL, Ochs HD, Fischer SH, et al. Home-based immunoglobulin infusion therapy: quality of life and patient health perceptions. Ann Allergy (1991) 67:504-10.
6. Gardulf A, Borte M, Ochs HD, Nicolay U, Vivaglobin Clinical Study Group. Prognostic factors for health-related quality of life in adults and children with primary antibody deficiencies receiving SCIG home therapy. Clin Immunol (2008) 126:81-8. doi:10.1016/j.clim.2007.06.009
7. Quinti I, Di Pietro C, Martini H, Pesce AM, Lombardi F, Baumghartner M, et al. Health related quality of life in common variable immunodeficiency. Yonsei Med J (2012) 53:603-10. doi:10.3349/ymj.2012.53.3.603
8. López-Pérez P, Miranda-Novales G, Segura-Méndez NH, Del Rivero-Hernández L, Cambray-Gutiérrez C, Chávez-García A. Study of quality of life in adults with common variable immunodeficiency by using the Questionnaire SF-36. Rev Alerg Mex (2014) 61:52-8.
9. Eades-Perner AM, Gathmann B, Knerr V, Guzman D, Veit D, Kindle G, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol (2007) 147:306-12. doi:10.1111/j.1365-2249.2006.03292.x
10. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol (1999) 93:190-7. doi:10.1006/clim.1999.4799
11. Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 30:473-83. doi:10.1097/00005650-199206000-00002
12. Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol (1998) 51:1025-36. doi:10.1016/S0895-4356(98)00094-8
13. Goldberg D. The Detection of Psychiatric Illness by Questionnaire. London: Oxford University Press (1972).
14. Picardi A, Abeni D, Pasquini P. Assessing psychological distress in patients with skin diseases: reliability, validity and factor structure of the GHQ-12. J Eur Acad Dermatol Venereol (2001) 15:410-7. doi:10.1046/j.1468-3083.2001.00336.x
15. Quinti I, Soresina A, Guerra A, Rondelli R, Spadaro G, Agostini C, et al. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a Multicenter Prospective Cohort Study. J Clin Immunol (2011) 31:315-22. doi:10.1007/s10875-011-9511-0
16. Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood (2008) 11:77-85. doi:10.1182/blood-2007-06-091744
17. Ochs HD, Fischer SH, Wedgwood RJ, Wara DW, Cowan MJ, Ammann AJ. Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases. Am J Med (1984) 76:78-82. doi:10.1016/0002-9343(84)90324-3
18. Orange JS, Grossman WJ, Navickis RJ, Wilkes MM. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies. Clin Immunol (2010) 137:21-30. doi:10.1016/j.clim.2010.06.012
19. Lohr KN. Applications of health status assessment measures in clinical practice. Overview of the third conference on advances in health status assessment. Med Care (1992) 30(5 Suppl):MS1-14. doi:10.1097/00005650-199205001-00001
20. Higginson IJ, Carr AJ. Measuring quality of life: using quality of life measures in the clinical setting. BMJ (2001) 322:1297-300. doi:10.1136/bmj.322.7297.1297
21. Lohr KN. Advances in health status assessment. Overview of the conference. Med Care (1989) 27(3 Suppl):S1-11. doi:10.1097/00005650-198903001-00001
22. Kuburovic NB, Pasic S, Susic G, Stevanovic D, Kuburovic V, Zdravkovic S, et al. Health-related quality of life, anxiety, and depressive symptoms in children with primary immunodeficiencies. Patient Prefer Adherence (2014) 17(8):323-30. doi:10.2147/PPA.S58040
23. Tcheurekdjian H, Palermo T, Hostoffer R. Quality of life in common variable immunodeficiency requiring intravenous immunoglobulin therapy. Ann Allergy Asthma Immunol (2004) 93:160-5. doi:10.1016/S1081-1206(10)61469-X
24. Quinti I, Agostini C, Tabolli S, Brunetti G, Cinetto F, Pecoraro A, et al. Malignancies are the major cause of death in patients with adult onset common variable immunodeficiency. Blood (2012) 120:1953-4. doi:10.1182/blood-2012-05-431064
25. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood (2012) 119:1650-7. doi:10.1182/blood-2011-09-377945